Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.28 - $1.16 $52,781 - $218,666
-188,506 Reduced 48.67%
198,800 $65,000
Q1 2024

May 15, 2024

BUY
$1.06 - $1.67 $85,302 - $134,391
80,474 Added 26.23%
387,306 $449,000
Q4 2023

Feb 14, 2024

BUY
$1.26 - $1.79 $16,977 - $24,118
13,474 Added 4.59%
306,832 $518,000
Q3 2023

Nov 14, 2023

BUY
$1.61 - $2.54 $34,381 - $54,241
21,355 Added 7.85%
293,358 $530,000
Q2 2023

Aug 14, 2023

BUY
$1.14 - $1.95 $273,048 - $467,056
239,516 Added 737.27%
272,003 $505,000
Q1 2023

May 12, 2023

SELL
$1.2 - $2.19 $528 - $963
-440 Reduced 1.34%
32,487 $43,000
Q4 2022

Feb 14, 2023

SELL
$1.63 - $3.52 $9,062 - $19,571
-5,560 Reduced 14.45%
32,927 $55,000
Q3 2022

Nov 14, 2022

BUY
$0.73 - $3.74 $18,250 - $93,500
25,000 Added 185.36%
38,487 $120,000
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $29,671 - $56,645
13,487 New
13,487 $32,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.